Skip to main content
. 2023 May 22;13:1126721. doi: 10.3389/fonc.2023.1126721

Table 2.

The biodistribution of [18F]AlF-NOTA-ADH-1 in PDX xenograft model( x¯ ± SD, %ID/g.).

Organs Non-blocking group Blocking group
30min 60min 90min 120min 60min
Blood 0.69±0.22 0.40±0.18 0.39±0.11 0.41±0.07 0.35±0.14
Brain 0.62±0.14 0.99±0.47 0.63±0.18 0.51±0.27 0.86±0.21
Heart 2.54±0.97 0.96±0.17 0.95±0.25 0.81±0.28 0.82±0.02
Lung 4.38±1.33 3.41±0.44 3.52±1.76 2.07±0.94 2.37±0.14
Liver 12.28±1.23 11.31±2.30 10.43±1.97 9.20±1.66 10.35±1.15
Spleen 1.81±0.48 1.41±0.24 1.13±0.03 0.86±0.25 1.25±0.20
Kidney 17.75±5.89 15.82±1.17 12.50±0.89 8.52±2.09 11.62±2.40
Stomach 3.23±1.69 3.40±0.12 6.16±1.58 1.60±1.04 2.24±0.16
Intestines 3.82±0.12 2.14±0.04 3.93±2.67 2.53±2.00 2.49±0.33
Muscle 1.41±0.20 1.56±0.07 2.03±0.05 1.18±0.60 1.68±0.06
Bone 1.74±0.81 2.29±0.96 1.65±1.30 0.74±0.35 2.16±0.09
Skin 0.11±0.04 0.95±0.46 1.51±0.02 1.56±0.66 0.54±0.14
Tumor 8.04±1.82 10.76±2.16 7.18±0.53 4.93±1.65 3.75±0.07
T/Blood 10.72± 1.02 19.21± 2.20 13.54± 0.35 10.27±1.36 9.39± 0.10
T/Muscle 5.69±0.72 8.70±2.68 4.15±1.86 3.97±1.56 2.12±0.06